| No information of Name |
| Description | L-K6L9 shows antimicrobial and antibiofilm activities against P. aeruginosa from cystic fibrosis patients. L-K6L9 is stable and resistant to degradation by cystic fibrosis sputum proteases and will not induce bacterial resistance [1]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C90H174N22O15 |
|---|---|
| Molecular Weight | 1804.48000 |
| Exact Mass | 1803.35000 |
| PSA | 632.63000 |
| LogP | 12.85010 |